These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 19466620)

  • 21. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.
    Elovic EP; Brashear A; Kaelin D; Liu J; Millis SR; Barron R; Turkel C
    Arch Phys Med Rehabil; 2008 May; 89(5):799-806. PubMed ID: 18452724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parent-proxy ratings of pain before and after botulinum toxin type A treatment for children with spasticity and cerebral palsy.
    Rivard PF; Nugent AC; Symons FJ
    Clin J Pain; 2009 Jun; 25(5):413-7. PubMed ID: 19454875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Botulinum toxin as a treatment for infantile cerebral palsy].
    Pascual-Pascual SI; Sánchez de Muniain P; Roche MC; Pascual-Castroviejo I
    Rev Neurol; 1997 Sep; 25(145):1369-75. PubMed ID: 9377292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of multilevel botulinum toxin a and comprehensive rehabilitation on gait in cerebral palsy.
    Scholtes VA; Dallmeijer AJ; Knol DL; Speth LA; Maathuis CG; Jongerius PH; Becher JG
    Pediatr Neurol; 2007 Jan; 36(1):30-9. PubMed ID: 17162194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Botulinum toxin: a new dimension for spasticity].
    Reichel G
    MMW Fortschr Med; 2007 May; 149 Suppl 2():65-9. PubMed ID: 17724971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical research of electroacupuncture combined with acupoint-injection of botulinum toxin A in treating the muscle spasticity by spinal cord injury].
    Xing ST; Wang D; Wen XH; Wu ZQ; Sun Q; Zhang DW; Cheng Y; Yan D; Yu F
    Zhongguo Gu Shang; 2010 May; 23(5):350-3. PubMed ID: 20575288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Botulinum toxin type A treatment of upper limb spasticity].
    Wissel M; Wissel J
    Wien Klin Wochenschr; 2001; 113 Suppl 4():16-9. PubMed ID: 15506047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term effect of botulinum toxin (A) in the management of calf spasticity in children with diplegic cerebral palsy.
    Hawamdeh ZM; Ibrahim AI; Al-Qudah AA
    Eura Medicophys; 2007 Sep; 43(3):311-8. PubMed ID: 17268388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of botulinum toxin A in the treatment of spasticity of the lower extremities in adults - preliminary report.
    Opara J; Hordyńska E; Swoboda A
    Ortop Traumatol Rehabil; 2007; 9(3):277-85. PubMed ID: 17721426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botulinum toxin-a in children with congenital spastic hemiplegia does not improve upper extremity motor-related function over rehabilitation alone: a randomized controlled trial.
    Rameckers EA; Speth LA; Duysens J; Vles JS; Smits-Engelsman BC
    Neurorehabil Neural Repair; 2009; 23(3):218-25. PubMed ID: 19106252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visual Analogue Scale to score the effects of Botulinum Toxin A treatment in children with cerebral palsy in daily clinical practice.
    Vles GF; de Louw AJ; Speth LA; van Rhijn LW; Janssen-Potten YJ; Hendriksen JG; Vles JS
    Eur J Paediatr Neurol; 2008 May; 12(3):231-8. PubMed ID: 17933567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Focal spasticity therapy with botulinum toxin: effects on function, activities of daily living and pain in 100 adult patients.
    Bergfeldt U; Borg K; Kullander K; Julin P
    J Rehabil Med; 2006 May; 38(3):166-71. PubMed ID: 16702083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of botulinum toxin type A on gait of children who are idiopathic toe-walkers.
    Brunt D; Woo R; Kim HD; Ko MS; Senesac C; Li S
    J Surg Orthop Adv; 2004; 13(3):149-55. PubMed ID: 15559690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal examination of health outcomes associated with botulinum toxin use in children with cerebral palsy.
    Balkrishnan R; Manuel JC; Smith BP; Camacho FT; Koman LA
    J Surg Orthop Adv; 2004; 13(2):76-80. PubMed ID: 15281403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective study examining remote effects of botulinum toxin a in children with cerebral palsy.
    Crowner BE; Racette BA
    Pediatr Neurol; 2008 Oct; 39(4):253-8. PubMed ID: 18805363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuous intrathecal baclofen for children with spasticity and/or dystonia: Goal attainment and complications associated with treatment.
    Ward A; Hayden S; Dexter M; Scheinberg A
    J Paediatr Child Health; 2009 Dec; 45(12):720-6. PubMed ID: 19863710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Frequency of side effects after botulinum toxin A injections in neurology, rehabilitation and gastroenterology].
    Sławek J; Madaliński MH; Maciag-Tymecka I; Duzyński W
    Pol Merkur Lekarski; 2005 Mar; 18(105):298-302. PubMed ID: 15997637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulinum toxin A--injection for cervical dystonia.
    Bhaumik S; Behari M
    J Assoc Physicians India; 1999 Mar; 47(3):267-70. PubMed ID: 10999117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of nonoccupational limb and trunk dystonia with botulinum toxin.
    Quirk JA; Sheean GL; Marsden CD; Lees AJ
    Mov Disord; 1996 Jul; 11(4):377-83. PubMed ID: 8813216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum toxin dilution and endplate targeting in spasticity: a double-blind controlled study.
    Gracies JM; Lugassy M; Weisz DJ; Vecchio M; Flanagan S; Simpson DM
    Arch Phys Med Rehabil; 2009 Jan; 90(1):9-16.e2. PubMed ID: 19154823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.